Please Wait
Applying Filters...
menu
    • menu
    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    Data Compilation
    #PharmaFlow

    Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

    Stock Recap
    #PipelineProspector

    Menu

    Chondroitin Sulfate Sodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 69Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    04/06/2025 Bioiberica
    Spain
    		 BIOIBERICA, S.A.U. Palafolls ES R1-CEP 2006-209 - Rev 04 Chondroitin sulfate sodium, Terrestrial origin 2021-11-10 Valid Chemical and TSE 2064
    04/06/2025 Bioiberica
    Spain
    		 BIOIBERICA, S.A.U. Palafolls ES CEP 2023-243 - Rev 02 Chondroitin sulfate sodium, Terrestrial origin, Process B 2024-12-18 Valid Chemical and TSE 2064